View:
SECURITIES AND SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934 (Amendment No. 3)*
BioTime, Inc.
................................................................................
(Name of Issuer)
Common Shares, no par value
................................................................................
(Title of Class of Securities)
09066L105
................................................................................
(CUSIP Number)
Hal Sternberg
935 Pardee Street, Berkeley, California 94710; (510) 845-9535
................................................................................
(Name, Address and Telephone Number of Person Authorized to Receive Notices
and Communications)
September 16, 1997
................................................................................
(Date of Event which Requires Filing this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
Note:Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are to be
sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
CUSIP No. 09066L105
1) Names of Reporting Persons S.S. or I.R.S. Identification Nos.
of Above Persons
Hal Sternberg
2) Check the Appropriate Box if a Member of a Group
(See Instructions)
(a) [ ]
(b) [ ]
3) SEC Use Only
4) Source of Funds (See Instructions)
PF; OO
5) Check if Disclosure of Legal Proceedings is Required Pursuant
to Items 2(d) or 2(e) [ ]
6) Citizenship or Place of Organization
U.S.A.
7) Sole Voting Power
Number of 158,379
Shares
Beneficially 8) Shared Voting Power
Owned by 0
Each
Reporting 9) Sole Dispositive Power
Person With 158,379
10) Shared Dispositive Power
0
11) Aggregate Amount Beneficially Owned by Each Reporting Person
158,379
12) Check if the Aggregate Amount in Row (11) Excludes Certain
Shares (See Instructions) [ ]
13) Percent of Class Represented by Amount in Row (11)
4.8%
14) Type of Reporting Person (See Instructions)
IN
Page 2 of 4 Pages
Item 1. Security and Issuer
The class of equity securities to which this schedule relates is Common
Shares, no par value (the "Common Shares"), of BioTime, Inc., a California
corporation (the "Company"). The Company has its principal executive offices at
935 Pardee Street, Berkeley, California 94710.
This schedule is being filed pursuant to Section 13(d) of the
Securities Exchange Act of 1934, as amended (the "Exchange Act") and the rules
and regulations promulgated thereunder.
Item 2. Identity and Background
(a) The name of the person filing this schedule is Hal Sternberg.
(b) The business address of Hal Sternberg is 935 Pardee Street, Berkeley,
California 94710.
(c) Hal Sternberg is currently the Vice President of Research of BioTime,
Inc., 935 Pardee Street, Berkeley, California 94710.
(d) Hal Sternberg has not been convicted during the last five years in a
criminal proceeding, excluding traffic violations or similar
misdemeanors.
(e) Hal Sternberg has not been a party during the last five years to any
civil proceeding of a judicial or administrative body of competent
jurisdiction, and has not, as a result of such a proceeding, been
subject to a judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject to,
federal or state securities laws or finding any violation with respect
to such laws.
(f) Hal Sternberg is a citizen of the United States of America.
Item 3. Source and Amount of Funds or Other Consideration
Not Applicable
Item 4. Purpose of Transaction
Hal Sternberg beneficially owns less than 5% of the outstanding Common
Shares of the Company.
Page 3 of 4 Pages
Item 5. Interest in Securities of the Issuer
Hal Sternberg beneficially owns less than 5% of the outstanding Common
Shares of the Company.
Item 6. Contracts, Arrangements,Understandings or Relationships with Respect to
Securities of the Issuer
Not Applicable.
Item 7. Material to Be Filed as Exhibits
Not Applicable.
Signature
After reasonable inquiry and to the best of my knowledge I certify that
the information set forth in the statement is true, complete and correct.
/s/: Hal Sternberg
Dated: September 24, 1997 ___________________________________
Hal Sternberg
Page 4 of 4 Pages